Apple AirPods Pro 3 vs Resound Vivia 9 60S microRIE

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid released in 2025, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $250, it sits in the most affordable price tier of OTC devices, though its overall sound performance ranks #49 of 65 in the category. This device delivers standout performance in music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect excellent stability without whistling or squealing during normal use. These strengths make the AirPods Pro 3 particularly appealing for users who prioritize media consumption alongside hearing assistance. However, speech clarity presents a more mixed picture. Speech in quiet scores 2.3/5, falling 0.53 points below the category average. Speech in noise measures 1.8/5, which is above the category average but still low in absolute terms. Own-voice comfort also trails at 1.9/5, sitting 0.61 points below typical OTC performance. The AirPods Pro 3 is best suited for users already invested in the Apple ecosystem who want hearing assistance combined with premium streaming quality. Those prioritizing speech understanding in conversations may want to explore alternatives like the Apple AirPods Pro 2, which scores higher overall at a lower listed price, or the Elehear Beyond at the top of this price range.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.